Direct benefits to the participants, who are diagnosed with celiac disease may be substantial
and could include lessening or prevention of GI symptoms, correction of biochemical
abnormalities and reduction in risk for malignancies or bone disease which are most common in
untreated celiac disease. However, the precise benefit is unknown and the motivation for this
proposed study. If these individuals have a positive celiac serology test at the present time
there is a high likelihood that they may have celiac disease.